Lv41
478 积分 2026-11-14 加入
ICH M12 Drug Interaction Studies: Summary of the Efforts to Achieve Global Convergence
32分钟前
已完结
Inhibition of human UDP-glucuronosyltransferase enzyme by entrectinib: Implications for drug-drug interactions
34分钟前
已完结
Inhibition of Four Anaplastic Lymphoma Kinase Inhibitors on the Activity of Human UDP-Glucuronosyltransferases and Prediction of Drug–Drug Interactions
35分钟前
已完结
Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by darolutamide: Prediction of in vivo drug-drug interactions
36分钟前
已完结
Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: Implications for drug-drug interactions
38分钟前
已完结
Tyrosine Kinase Inhibitors in Cancers: Treatment optimization – Part II
1小时前
已完结
Clinical pharmacokinetics and drug–drug interactions of tyrosine-kinase inhibitors in chronic myeloid leukemia: A clinical perspective
1小时前
已完结
Role of CYP3A4 in the metabolism of tyrosine kinase inhibitors in non–small cell lung cancer therapy
1小时前
已关闭
Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management
1小时前
已完结